ask="5.75"
ask_size="200"
average_daily_volume="149053"
bid="3.84"
bid_size="100"
book_value="2.54"
change="-0.25"
change_from_200_day_moving_average="-1.76"
change_from_50_day_moving_average="0.12"
change_from_52_week_high="-7.33"
change_From_52_week_low="0.50"
change_in_percent="-5.54%"
close="4.26"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="-74.76M"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.17"
ex_dividend_date="N/A"
float_shares="23413000"
high="4.55"
high_52_weeks="11.59"
last_trade_date="1/23/2017"
last_trade_price="4.26"
last_trade_size="384"
last_trade_time="4:00pm"
low="4.22"
low_52_weeks="3.76"
market_capitalization="301.54M"
moving_average_200_day="6.02"
moving_average_50_day="4.14"
name="Adaptimmune Therapeutics plc"
notes="N/A"
one_year_target_price="15.20"
open="4.53"
pe_ratio="N/A"
peg_ratio="0.32"
percent_change_from_200_day_moving_average="-29.24%"
percent_change_from_50_day_moving_average="+2.95%"
percent_change_from_52_week_high="-63.24%"
percent_change_from_52_week_low="+13.30%"
previous_close="4.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.77"
price_per_sales="33.52"
revenue="9.52M"
shares_outstanding="70785000"
short_ratio="3.43"
stock_exchange="NMS"
symbol="ADAP"
volume="137997"
weeks_range_52="3.76 - 11.59"
